![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Classification of Omicron BA.1, BA.1.1, and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data
Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 486-491
Open Access | Times Cited: 13
Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 486-491
Open Access | Times Cited: 13
Showing 13 citing articles:
Recombination in Coronaviruses, with a Focus on SARS-CoV-2
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 6, pp. 1239-1239
Open Access | Times Cited: 96
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 6, pp. 1239-1239
Open Access | Times Cited: 96
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 41
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 41
SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022
Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, et al.
Journal of Infection (2022) Vol. 85, Iss. 2, pp. 174-211
Open Access | Times Cited: 22
Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, et al.
Journal of Infection (2022) Vol. 85, Iss. 2, pp. 174-211
Open Access | Times Cited: 22
Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2
Phoomintara Longsompurana, Thanyada Rungrotmongkol, Nongluk Plongthongkum, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293263-e0293263
Open Access | Times Cited: 7
Phoomintara Longsompurana, Thanyada Rungrotmongkol, Nongluk Plongthongkum, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293263-e0293263
Open Access | Times Cited: 7
Effectiveness of the severe acute respiratory syndrome coronavirus 2 Omicron BA.5 bivalent vaccine on symptoms in healthcare workers with BA.5 infection
Yosuke Hirotsu, Mika Takatori, Hitoshi Mochizuki, et al.
Vaccine X (2024) Vol. 17, pp. 100433-100433
Open Access | Times Cited: 1
Yosuke Hirotsu, Mika Takatori, Hitoshi Mochizuki, et al.
Vaccine X (2024) Vol. 17, pp. 100433-100433
Open Access | Times Cited: 1
Detection of the Omicron BA.2.75 subvariant in Japan
Yosuke Hirotsu, Masao Omata
Journal of Infection (2022) Vol. 86, Iss. 1, pp. e5-e7
Open Access | Times Cited: 7
Yosuke Hirotsu, Masao Omata
Journal of Infection (2022) Vol. 86, Iss. 1, pp. e5-e7
Open Access | Times Cited: 7
Genomic evidence for reinfection with different Omicron subvariants
Yosuke Hirotsu, Masao Omata
Journal of Infection (2023) Vol. 86, Iss. 3, pp. e61-e63
Open Access | Times Cited: 3
Yosuke Hirotsu, Masao Omata
Journal of Infection (2023) Vol. 86, Iss. 3, pp. e61-e63
Open Access | Times Cited: 3
Clinical features of SARS-CoV-2 Omicron BA.2; Lessons from previous observations – Correspondence
Saeed Sahebi, Masoud Keikha
International Journal of Surgery (2022) Vol. 104, pp. 106754-106754
Open Access | Times Cited: 5
Saeed Sahebi, Masoud Keikha
International Journal of Surgery (2022) Vol. 104, pp. 106754-106754
Open Access | Times Cited: 5
Accelerating pandemic response with the emergency Omicron RT‐PCR test: A comprehensive solution for COVID‐19 diagnosis and tracking
Hsing‐Yi Chung, Ming‐Jr Jian, Chih‐Kai Chang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 2
Hsing‐Yi Chung, Ming‐Jr Jian, Chih‐Kai Chang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 2
Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay
Akira Aoki, Hirokazu Adachi, Yoko Mori, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2401-2401
Open Access | Times Cited: 4
Akira Aoki, Hirokazu Adachi, Yoko Mori, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2401-2401
Open Access | Times Cited: 4
Peripheral Blood CD8+T Cell as a Prognostic Biomarker for Hospitalised COVID-19 Patients Without Antiviral Treatment
Yuming Sun, Peilin Liu, Lifang Zhang, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 109-117
Open Access
Yuming Sun, Peilin Liu, Lifang Zhang, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 109-117
Open Access
Omicron B.A 2: Vaccine Construction with MHC Class-I, MHC Class-II by Using Bioinformatics Tools
Muhammad Waqar Mazhar
Archives of Immunology Research and Therapy (2024) Vol. 3, Iss. 1
Open Access
Muhammad Waqar Mazhar
Archives of Immunology Research and Therapy (2024) Vol. 3, Iss. 1
Open Access
SARS-CoV-2 recombinant XN, Italy
Federica Novazzi, Daniele Focosi, Andreina Baj, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 3, pp. 100084-100084
Open Access | Times Cited: 3
Federica Novazzi, Daniele Focosi, Andreina Baj, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 3, pp. 100084-100084
Open Access | Times Cited: 3